During the recent session, GoodRx Holdings Inc (NASDAQ:GDRX)’s traded shares were 0.51 million, with the beta value of the company hitting 1.40. At the last check today, the stock’s price was $8.03, reflecting an intraday loss of -2.15% or -$0.18. The 52-week high for the GDRX share is $9.26, that puts it down -15.32 from that peak though still a striking 48.44% gain since the share price plummeted to a 52-week low of $4.14. The company’s market capitalization is $3.05B, and the average intraday trading volume over the past 10 days was 1.52 million shares, and the average trade volume was 1.40 million shares over the past three months.
GoodRx Holdings Inc (GDRX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. GDRX has a Sell rating from 0 analyst(s) out of 16 analysts who have looked at this stock. 7 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 9 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.09.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GoodRx Holdings Inc (NASDAQ:GDRX) trade information
GoodRx Holdings Inc (GDRX) registered a -2.15% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.15% in intraday trading to $8.03, hitting a weekly high. The stock’s 5-day price performance is -2.39%, and it has moved by -8.19% in 30 days. Based on these gigs, the overall price performance for the year is 22.27%. The short interest in GoodRx Holdings Inc (NASDAQ:GDRX) is 8.21 million shares and it means that shorts have 4.89 day(s) to cover.
The consensus price target of analysts on Wall Street is $10, which implies an increase of 19.7% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $45 respectively. As a result, GDRX is trading at a discount of -460.4% off the target high and 62.64% off the low.
GoodRx Holdings Inc (GDRX) estimates and forecasts
Statistics show that GoodRx Holdings Inc has outperformed its competitors in share price, compared to the industry in which it operates. GoodRx Holdings Inc (GDRX) shares have gone down -3.79% during the last six months, with a year-to-date growth rate more than the industry average at 25.00% against 8.40. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 50.00% this quarter and then jump 12.50% in the quarter after that. In the rating firms’ projections, revenue will increase 6.70% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 195.65M as predicted by 14 analyst(s). Meanwhile, a consensus of 14 analyst(s) estimates revenue growth to 206.37M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 179.96M and 196.64M respectively. In this case, analysts expect current quarter sales to grow by 8.70% and then jump by 4.90% in the coming quarter.
While earnings are projected to return 24.07% in 2024, the next five years will return 30.00% per annum.
GDRX Dividends
GoodRx Holdings Inc is due to release its next quarterly earnings on 2024-Nov-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
GoodRx Holdings Inc (NASDAQ:GDRX)’s Major holders
GoodRx Holdings Inc insiders own 12.71% of total outstanding shares while institutional holders control 66.20%, with the float percentage being 75.84%. FRANCISCO PARTNERS MANAGEMENT, LP is the largest shareholder of the company, while 216.0 institutions own stock in it. As of 2024-06-30, the company held over 70.08 million shares (or 17.9666% of all shares), a total value of $546.61 million in shares.
The next largest institutional holding, with 8.13 million shares, is of VANGUARD GROUP INC’s that is approximately 2.0849% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $63.43 million.
